Cargando…

Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data

BACKGROUND: Individualized drug response prediction is vital for achieving personalized treatment of cancer and moving precision medicine forward. Large-scale multi-omics profiles provide unprecedented opportunities for precision cancer therapy. METHODS: In this study, we propose a pipeline to ident...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yanjun, Dong, Qun, Li, Feng, Xu, Yingqi, Hu, Congxue, Wang, Jingwen, Shang, Desi, Zheng, Xuan, Yang, Haixiu, Zhang, Chunlong, Shao, Mengting, Meng, Mohan, Xiong, Zhiying, Li, Xia, Zhang, Yunpeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685260/ https://www.ncbi.nlm.nih.gov/pubmed/31387579 http://dx.doi.org/10.1186/s12967-019-2010-4

Ejemplares similares

Identifying individualized risk subpathways reveals pan-cancer molecular classification based on multi-omics data
por: Xu, Yanjun, et al.
Publicado: (2022)

LncSubpathway: a novel approach for identifying dysfunctional subpathways associated with risk lncRNAs by integrating lncRNA and mRNA expression profiles and pathway topologies
por: Xu, Yanjun, et al.
Publicado: (2017)

Subpathway-GMir: identifying miRNA-mediated metabolic subpathways by integrating condition-specific genes, microRNAs, and pathway topologies
por: Feng, Li, et al.
Publicado: (2015)

Integrating gene and lncRNA expression to infer subpathway activity for tumor analyses
por: Zhang, Chunlong, et al.
Publicado: (2017)

Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways
por: Li, Chunquan, et al.
Publicado: (2013)

Characterizing the Network of Drugs and Their Affected Metabolic Subpathways
por: Li, Chunquan, et al.
Publicado: (2012)

Cofunctional Subpathways Were Regulated by Transcription Factor with Common Motif, Common Family, or Common Tissue
por: Su, Fei, et al.
Publicado: (2015)

Quantifying Risk Pathway Crosstalk Mediated by miRNA to Screen Precision drugs for Breast Cancer Patients
por: Xu, Yingqi, et al.
Publicado: (2019)

Comprehensive analysis of microglia gene and subpathway signatures for glioma prognosis and drug screening: linking microglia to glioma
por: Zhang, Chunlong, et al.
Publicado: (2022)

Subpathway-LNCE: Identify dysfunctional subpathways competitively regulated by lncRNAs through integrating lncRNA-mRNA expression profile and pathway topologies
por: Shi, Xinrui, et al.
Publicado: (2016)

Inference of patient‐specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer
por: Han, Junwei, et al.
Publicado: (2018)

Global Prioritization of Disease Candidate Metabolites Based on a Multi-omics Composite Network
por: Yao, Qianlan, et al.
Publicado: (2015)

Dissecting immune cell stat regulation network reveals biomarkers to predict ICB therapy responders in melanoma
por: Wang, Jingwen, et al.
Publicado: (2021)

The Implications of Relationships between Human Diseases and Metabolic Subpathways
por: Li, Xia, et al.
Publicado: (2011)

ncDRMarker: a computational method for identifying non-coding RNA signatures of drug resistance based on heterogeneous network
por: Yang, Haixiu, et al.
Publicado: (2020)

The LncRNA Connectivity Map: Using LncRNA Signatures to Connect Small Molecules, LncRNAs, and Diseases
por: Yang, Haixiu, et al.
Publicado: (2017)

BioM2MetDisease: a manually curated database for associations between microRNAs, metabolites, small molecules and metabolic diseases
por: Xu, Yanjun, et al.
Publicado: (2017)

Identification of a robust functional subpathway signature for pancreatic ductal adenocarcinoma by comprehensive and integrated analyses
por: Wang, Ping, et al.
Publicado: (2020)

Prioritizing Candidate Disease Metabolites Based on Global Functional Relationships between Metabolites in the Context of Metabolic Pathways
por: Shang, Desi, et al.
Publicado: (2014)

System level characterization of small molecule drugs and their affected long noncoding RNAs
por: Yang, Haixiu, et al.
Publicado: (2019)

Global view of a drug-sensitivity gene network
por: Yang, Haixiu, et al.
Publicado: (2017)

Comprehensive analysis of mRNA‐level and miRNA‐level subpathway activities for identifying robust ovarian cancer prognostic signatures
por: Tian, Songyu, et al.
Publicado: (2020)

LncRNAs2Pathways: Identifying the pathways influenced by a set of lncRNAs of interest based on a global network propagation method
por: Han, Junwei, et al.
Publicado: (2017)

ESEA: Discovering the Dysregulated Pathways based on Edge Set Enrichment Analysis
por: Han, Junwei, et al.
Publicado: (2015)

Subpathway-CorSP: Identification of metabolic subpathways via integrating expression correlations and topological features between metabolites and genes of interest within pathways
por: Feng, Chenchen, et al.
Publicado: (2016)

ce‐Subpathway: Identification of ceRNA‐mediated subpathways via joint power of ceRNAs and pathway topologies
por: Feng, Chenchen, et al.
Publicado: (2018)

Inference of Subpathway Activity Profiles Reveals Metabolism Abnormal Subpathway Regions in Glioblastoma Multiforme
por: Han, Xudong, et al.
Publicado: (2020)

sPAGM: inferring subpathway activity by integrating gene and miRNA expression-robust functional signature identification for melanoma prognoses
por: Zhang, Chun-Long, et al.
Publicado: (2017)

Topologically inferring active miRNA‐mediated subpathways toward precise cancer classification by directed random walk
por: Ning, Ziyu, et al.
Publicado: (2019)

SubpathwayMiner: a software package for flexible identification of pathways
por: Li, Chunquan, et al.
Publicado: (2009)

Integrative Pathway Analysis of Genes and Metabolites Reveals Metabolism Abnormal Subpathway Regions and Modules in Esophageal Squamous Cell Carcinoma
por: Li, Chunquan, et al.
Publicado: (2017)

Identification and Functional Analysis of Individual-Specific Subpathways in Lung Adenocarcinoma
por: Fang, Jingya, et al.
Publicado: (2022)

Subpathway Analysis based on Signaling-Pathway Impact Analysis of Signaling Pathway
por: Li, Xianbin, et al.
Publicado: (2015)

MPINet: Metabolite Pathway Identification via Coupling of Global Metabolite Network Structure and Metabolomic Profile
por: Li, Feng, et al.
Publicado: (2014)

Characterizing heterogeneity of non‐small cell lung tumour microenvironment to identify signature prognostic genes
por: Mi, Kai, et al.
Publicado: (2020)

Identification of Subtype Specific miRNA-mRNA Functional Regulatory Modules in Matched miRNA-mRNA Expression Data: Multiple Myeloma as a Case
por: Zhang, Yunpeng, et al.
Publicado: (2015)

Identifying and characterizing drug sensitivity-related lncRNA-TF-gene regulatory triplets
por: Hu, Congxue, et al.
Publicado: (2022)

Homologous Recombination Subpathways: A Tangle to Resolve
por: Elbakry, Amira, et al.
Publicado: (2021)

Integrating subpathway analysis to identify candidate agents for hepatocellular carcinoma
por: Wang, Jiye, et al.
Publicado: (2016)

Identification of Cancer Dysfunctional Subpathways by Integrating DNA Methylation, Copy Number Variation, and Gene-Expression Data
por: Liu, Siyao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_isiie0mics4tr96f0gh5qeu1or